ONTOLOGY REPORT - ANNOTATIONS
| Term: | N-acetyl-L-cysteine |
|
| Accession: | CHEBI:28939
|
browse the term
|
| Definition: | The N-acetylated derivative of natural amino acid L-cysteine. |
| Synonyms: | related_synonym: | (2R)-2-acetylamino-3-sulfanylpropanoic acid; (R)-2-acetylamino-3-mercaptopropanoic acid; (R)-mercapturic acid; Acetylcysteine; C5H9NO3S; CC(=O)N[C@@H](CS)C(O)=O; InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1; InChIKey=PWKSKIMOESPYIA-BYPYZUCNSA-N; L-acetylcysteine; L-alpha-acetamido-beta-mercaptopropionic acid; N-acetylcysteine; acetilcisteina; acetylcysteinum; mercapturic acid |
| | alt_id: | CHEBI:21548; CHEBI:2418; CHEBI:45481 |
| | xref_casrn: | 616-91-1 |
| | xref: | Beilstein:1724426 "Beilstein Registry Number"; ChEMBL:120881 "ChEMBL COMPOUND"; ChemIDplus:616-91-1 "CAS Registry Number"; CiteXplore:10651166 "PubMed citation"; DrugBank:DB06151 "DrugBank"; Gmelin:142554 "Gmelin Registry Number"; KEGG COMPOUND:616-91-1 "CAS Registry Number"; KEGG COMPOUND:C06809 "KEGG COMPOUND"; KEGG DRUG:D00221 "KEGG DRUG" |
| | xref_mesh: | MESH:D000111 |
| | xref: | NIST Chemistry WebBook:616-91-1 "CAS Registry Number"; PDBeChem:SC2 "PDBeChem"; Wikipedia:Acetylcysteine "Wikipedia" |
|
|
N-acetyl-L-cysteine
|
| G |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
|
multiple interactions |
ISO |
7 |
87,133,179 |
87,342,639 |
RGD:6480464 |
CTD |
| G |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
EXP |
16 |
16,043,434 |
16,236,931 |
RGD:6480464 |
CTD |
| G |
ABCC1 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
|
multiple interactions |
EXP |
16 |
16,043,434 |
16,236,931 |
RGD:6480464 |
CTD |
| G |
ABCC3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
|
multiple interactions |
EXP |
17 |
48,712,218 |
48,769,063 |
RGD:6480464 |
CTD |
| G |
ABCG1 |
ATP-binding cassette, sub-family G (WHITE), member 1 |
|
decreases expression |
EXP |
21 |
43,619,799 |
43,717,354 |
RGD:6480464 |
CTD |
| G |
ABL1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
9 |
133,589,268 |
133,763,062 |
RGD:6480464 |
CTD |
| G |
ACHE |
acetylcholinesterase |
|
multiple interactions |
ISO |
7 |
100,487,615 |
100,493,541 |
RGD:6480464 |
CTD |
| G |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
EXP |
10 |
90,694,831 |
90,751,147 |
RGD:6480464 |
CTD |
| G |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
|
multiple interactions |
ISO |
10 |
90,694,831 |
90,751,147 |
RGD:6480464 |
CTD |
| G |
ADIPOQ |
adiponectin, C1Q and collagen domain containing |
|
multiple interactions |
ISO |
3 |
186,560,463 |
186,576,252 |
RGD:6480464 |
CTD |
| G |
AGER |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
EXP |
6 |
32,148,745 |
32,152,099 |
RGD:6480464 |
CTD |
| G |
AGT |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
multiple interactions |
ISO |
1 |
230,838,269 |
230,850,336 |
RGD:6480464 |
CTD |
| G |
AIFM1 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
|
multiple interactions |
EXP |
X |
129,263,337 |
129,299,861 |
RGD:6480464 |
CTD |
| G |
AIFM1 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
|
multiple interactions |
ISO |
X |
129,263,337 |
129,299,861 |
RGD:6480464 |
CTD |
| G |
AIFM1 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
|
multiple interactions |
EXP |
X |
129,263,337 |
129,299,861 |
RGD:6480464 |
CTD |
| G |
AIFM1 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
|
multiple interactions |
EXP |
X |
129,263,337 |
129,299,861 |
RGD:6480464 |
CTD |
| G |
AIFM1 |
apoptosis-inducing factor, mitochondrion-associated, 1 |
|
multiple interactions |
EXP |
X |
129,263,337 |
129,299,861 |
RGD:6480464 |
CTD |
| G |
AIMP1 |
aminoacyl tRNA synthetase complex-interacting multifunctional protein 1 |
|
decreases expression |
EXP |
4 |
107,236,767 |
107,270,382 |
RGD:6480464 |
CTD |
| G |
AKR1C3 |
aldo-keto reductase family 1, member C3 |
|
multiple interactions |
EXP |
10 |
5,090,958 |
5,149,878 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
AKT1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
14 |
105,235,686 |
105,262,080 |
RGD:6480464 |
CTD |
| G |
ALAD |
aminolevulinate dehydratase |
|
multiple interactions |
ISO |
9 |
116,148,592 |
116,163,618 |
RGD:6480464 |
CTD |
| G |
ALB |
albumin |
|
multiple interactions |
ISO |
4 |
74,269,972 |
74,287,129 |
RGD:6480464 |
CTD |
| G |
ALDH2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
EXP |
12 |
112,204,691 |
112,247,789 |
RGD:6480464 |
CTD |
| G |
ALK |
anaplastic lymphoma receptor tyrosine kinase |
|
multiple interactions |
EXP |
2 |
29,415,640 |
30,144,477 |
RGD:6480464 |
CTD |
| G |
AMACR |
alpha-methylacyl-CoA racemase |
|
multiple interactions |
EXP |
5 |
33,987,091 |
34,008,220 |
RGD:6480464 |
CTD |
| G |
ANGPT1 |
angiopoietin 1 |
|
decreases secretion |
EXP |
8 |
108,261,710 |
108,510,254 |
RGD:6480464 |
CTD |
| G |
APAF1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
12 |
99,039,078 |
99,129,211 |
RGD:6480464 |
CTD |
| G |
APAF1 |
apoptotic peptidase activating factor 1 |
|
multiple interactions |
ISO |
12 |
99,039,078 |
99,129,211 |
RGD:6480464 |
CTD |
| G |
APEX1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
multiple interactions |
EXP |
14 |
20,923,290 |
20,925,931 |
RGD:6480464 |
CTD |
| G |
APP |
amyloid beta (A4) precursor protein |
|
multiple interactions |
EXP |
21 |
27,252,861 |
27,543,446 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
AR |
androgen receptor |
|
multiple interactions |
EXP |
X |
66,763,874 |
66,950,461 |
RGD:6480464 |
CTD |
| G |
ARNT |
aryl hydrocarbon receptor nuclear translocator |
|
multiple interactions |
EXP |
1 |
150,782,181 |
150,849,244 |
RGD:6480464 |
CTD |
| G |
ART4 |
ADP-ribosyltransferase 4 (Dombrock blood group) |
|
decreases expression |
EXP |
12 |
14,982,245 |
14,996,413 |
RGD:6480464 |
CTD |
| G |
ATF2 |
activating transcription factor 2 |
|
multiple interactions |
ISO |
2 |
175,936,978 |
176,032,934 |
RGD:6480464 |
CTD |
| G |
ATF2 |
activating transcription factor 2 |
|
multiple interactions |
EXP |
2 |
175,936,978 |
176,032,934 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
multiple interactions |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATF4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
multiple interactions |
EXP |
22 |
39,916,569 |
39,918,691 |
RGD:6480464 |
CTD |
| G |
ATF6 |
activating transcription factor 6 |
|
multiple interactions |
EXP |
1 |
161,736,034 |
161,933,860 |
RGD:6480464 |
CTD |
| G |
ATF6 |
activating transcription factor 6 |
|
multiple interactions |
ISO |
1 |
161,736,034 |
161,933,860 |
RGD:6480464 |
CTD |
| G |
ATG12 |
autophagy related 12 |
|
multiple interactions |
EXP |
5 |
115,163,893 |
115,177,548 |
RGD:6480464 |
CTD |
| G |
ATG5 |
autophagy related 5 |
|
multiple interactions |
EXP |
6 |
106,632,352 |
106,773,695 |
RGD:6480464 |
CTD |
| G |
ATM |
ataxia telangiectasia mutated |
|
multiple interactions |
EXP |
11 |
108,093,559 |
108,239,826 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
increases expression |
EXP |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATP2A2 |
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2 |
|
multiple interactions |
ISO |
12 |
110,719,032 |
110,788,898 |
RGD:6480464 |
CTD |
| G |
ATXN1 |
ataxin 1 |
|
affects localization |
EXP |
6 |
16,299,343 |
16,761,721 |
RGD:6480464 |
CTD |
| G |
ATXN1 |
ataxin 1 |
|
multiple interactions |
EXP |
6 |
16,299,343 |
16,761,721 |
RGD:6480464 |
CTD |
| G |
B2M |
beta-2-microglobulin |
|
decreases response to substance |
EXP |
15 |
45,003,685 |
45,010,357 |
RGD:6480464 |
CTD |
| G |
B2M |
beta-2-microglobulin |
|
multiple interactions |
EXP |
15 |
45,003,685 |
45,010,357 |
RGD:6480464 |
CTD |
| G |
BACH1 |
BTB and CNC homology 1, basic leucine zipper transcription factor 1 |
|
multiple interactions |
EXP |
21 |
30,671,220 |
30,734,217 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BAD |
BCL2-associated agonist of cell death |
|
multiple interactions |
EXP |
11 |
64,037,300 |
64,052,176 |
RGD:6480464 |
CTD |
| G |
BAG3 |
BCL2-associated athanogene 3 |
|
multiple interactions |
EXP |
10 |
121,410,882 |
121,437,331 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
decreases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
increases expression |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
EXP |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BAX |
BCL2-associated X protein |
|
multiple interactions |
ISO |
19 |
49,458,117 |
49,465,055 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
decreases response to substance |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
EXP |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2 |
B-cell CLL/lymphoma 2 |
|
multiple interactions |
ISO |
18 |
60,790,579 |
60,986,613 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
ISO |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L1 |
BCL2-like 1 |
|
multiple interactions |
EXP |
20 |
30,252,261 |
30,310,656 |
RGD:6480464 |
CTD |
| G |
BCL2L11 |
BCL2-like 11 (apoptosis facilitator) |
|
multiple interactions |
EXP |
2 |
111,878,491 |
111,926,022 |
RGD:6480464 |
CTD |
| G |
BDKRB1 |
bradykinin receptor B1 |
|
multiple interactions |
ISO |
14 |
96,722,547 |
96,731,100 |
RGD:6480464 |
CTD |
| G |
BDNF |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
11 |
27,676,440 |
27,743,605 |
RGD:6480464 |
CTD |
| G |
BECN1 |
beclin 1, autophagy related |
|
multiple interactions |
EXP |
17 |
40,962,150 |
40,976,310 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
multiple interactions |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BID |
BH3 interacting domain death agonist |
|
multiple interactions |
EXP |
22 |
18,216,906 |
18,257,431 |
RGD:6480464 |
CTD |
| G |
BIRC2 |
baculoviral IAP repeat containing 2 |
|
multiple interactions |
EXP |
11 |
102,217,913 |
102,249,401 |
RGD:6480464 |
CTD |
| G |
BIRC3 |
baculoviral IAP repeat containing 3 |
|
multiple interactions |
EXP |
11 |
102,188,181 |
102,210,134 |
RGD:6480464 |
CTD |
| G |
BIRC5 |
baculoviral IAP repeat containing 5 |
|
multiple interactions |
EXP |
17 |
76,210,277 |
76,221,716 |
RGD:6480464 |
CTD |
| G |
BNIP3 |
BCL2/adenovirus E1B 19kDa interacting protein 3 |
|
multiple interactions |
ISO |
10 |
133,781,204 |
133,795,435 |
RGD:6480464 |
CTD |
| G |
BPGM |
2,3-bisphosphoglycerate mutase |
|
decreases expression |
EXP |
7 |
134,331,531 |
134,364,568 |
RGD:6480464 |
CTD |
| G |
BTG1 |
B-cell translocation gene 1, anti-proliferative |
|
decreases expression |
EXP |
12 |
92,534,054 |
92,539,673 |
RGD:6480464 |
CTD |
| G |
C20orf111 |
chromosome 20 open reading frame 111 |
|
multiple interactions |
EXP |
20 |
42,824,579 |
42,839,546 |
RGD:6480464 |
CTD |
| G |
CASP10 |
caspase 10, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,047,621 |
202,094,129 |
RGD:6480464 |
CTD |
| G |
CASP12 |
caspase 12 (gene/pseudogene) |
|
multiple interactions |
ISO |
11 |
104,756,445 |
104,769,397 |
RGD:6480464 |
CTD |
| G |
CASP14 |
caspase 14, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
19 |
15,160,291 |
15,169,104 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP2 |
caspase 2, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
7 |
142,985,308 |
143,004,789 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases cleavage |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
increases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
decreases activity |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP3 |
caspase 3, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
185,548,850 |
185,570,629 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP4 |
caspase 4, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
11 |
104,813,594 |
104,839,325 |
RGD:6480464 |
CTD |
| G |
CASP6 |
caspase 6, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
4 |
110,609,785 |
110,624,629 |
RGD:6480464 |
CTD |
| G |
CASP6 |
caspase 6, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
4 |
110,609,785 |
110,624,629 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP7 |
caspase 7, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
10 |
115,438,921 |
115,490,668 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP8 |
caspase 8, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
2 |
202,098,166 |
202,152,434 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
ISO |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CASP9 |
caspase 9, apoptosis-related cysteine peptidase |
|
multiple interactions |
EXP |
1 |
15,818,769 |
15,851,285 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
increases expression |
EXP |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAT |
catalase |
|
multiple interactions |
ISO |
11 |
34,460,472 |
34,493,607 |
RGD:6480464 |
CTD |
| G |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
|
decreases expression |
EXP |
7 |
116,164,839 |
116,201,239 |
RGD:6480464 |
CTD |
| G |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
|
multiple interactions |
EXP |
7 |
116,164,839 |
116,201,239 |
RGD:6480464 |
CTD |
| G |
CAV1 |
caveolin 1, caveolae protein, 22kDa |
|
multiple interactions |
EXP |
7 |
116,164,839 |
116,201,239 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
EXP |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
17 |
32,582,296 |
32,584,222 |
RGD:6480464 |
CTD |
| G |
CCL22 |
chemokine (C-C motif) ligand 22 |
|
multiple interactions |
EXP |
16 |
57,392,695 |
57,400,102 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
ISO |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCL5 |
chemokine (C-C motif) ligand 5 |
|
multiple interactions |
EXP |
17 |
34,198,495 |
34,207,377 |
RGD:6480464 |
CTD |
| G |
CCNA1 |
cyclin A1 |
|
multiple interactions |
EXP |
13 |
37,005,967 |
37,017,019 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
EXP |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
decreases expression |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND1 |
cyclin D1 |
|
multiple interactions |
ISO |
11 |
69,455,873 |
69,469,242 |
RGD:6480464 |
CTD |
| G |
CCND2 |
cyclin D2 |
|
multiple interactions |
ISO |
12 |
4,382,902 |
4,414,522 |
RGD:6480464 |
CTD |
| G |
CCNE1 |
cyclin E1 |
|
multiple interactions |
ISO |
19 |
30,302,901 |
30,315,215 |
RGD:6480464 |
CTD |
| G |
CD14 |
CD14 molecule |
|
multiple interactions |
EXP |
5 |
140,011,313 |
140,013,286 |
RGD:6480464 |
CTD |
| G |
CD40LG |
CD40 ligand |
|
multiple interactions |
ISO |
X |
135,730,336 |
135,742,549 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CD86 |
CD86 molecule |
|
multiple interactions |
EXP |
3 |
121,774,209 |
121,839,990 |
RGD:6480464 |
CTD |
| G |
CDH1 |
cadherin 1, type 1, E-cadherin (epithelial) |
|
multiple interactions |
EXP |
16 |
68,771,195 |
68,869,444 |
RGD:6480464 |
CTD |
| G |
CDH13 |
cadherin 13, H-cadherin (heart) |
|
decreases expression |
EXP |
16 |
82,660,399 |
83,830,215 |
RGD:6480464 |
CTD |
| G |
CDK4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
12 |
58,141,510 |
58,146,230 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
increases expression |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
EXP |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1A |
cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
|
multiple interactions |
ISO |
6 |
36,644,237 |
36,655,116 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
increases expression |
ISO |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CDKN1B |
cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
|
multiple interactions |
ISO |
12 |
12,870,302 |
12,875,305 |
RGD:6480464 |
CTD |
| G |
CFTR |
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
|
multiple interactions |
EXP |
7 |
117,120,017 |
117,308,719 |
RGD:6480464 |
CTD |
| G |
CHEK1 |
checkpoint kinase 1 |
|
multiple interactions |
EXP |
11 |
125,495,031 |
125,546,150 |
RGD:6480464 |
CTD |
| G |
CHEK2 |
checkpoint kinase 2 |
|
multiple interactions |
EXP |
22 |
29,083,731 |
29,137,822 |
RGD:6480464 |
CTD |
| G |
CHUK |
conserved helix-loop-helix ubiquitous kinase |
|
decreases activity |
EXP |
10 |
101,948,124 |
101,989,344 |
RGD:6480464 |
CTD |
| G |
CKB |
creatine kinase, brain |
|
multiple interactions |
ISO |
14 |
103,985,995 |
103,989,196 |
RGD:6480464 |
CTD |
| G |
CKM |
creatine kinase, muscle |
|
multiple interactions |
ISO |
19 |
45,809,671 |
45,826,235 |
RGD:6480464 |
CTD |
| G |
CLK1 |
CDC-like kinase 1 |
|
multiple interactions |
EXP |
2 |
201,717,732 |
201,729,467 |
RGD:6480464 |
CTD |
| G |
CNTF |
ciliary neurotrophic factor |
|
multiple interactions |
EXP |
11 |
58,390,146 |
58,393,206 |
RGD:6480464 |
CTD |
| G |
COL18A1 |
collagen, type XVIII, alpha 1 |
|
multiple interactions |
EXP |
21 |
46,825,097 |
46,933,634 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
decreases expression |
EXP |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
decreases expression |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
17 |
48,261,457 |
48,279,000 |
RGD:6480464 |
CTD |
| G |
COL1A2 |
collagen, type I, alpha 2 |
|
decreases expression |
EXP |
7 |
94,023,873 |
94,060,544 |
RGD:6480464 |
CTD |
| G |
COL4A1 |
collagen, type IV, alpha 1 |
|
decreases expression |
EXP |
13 |
110,801,310 |
110,959,496 |
RGD:6480464 |
CTD |
| G |
CPE |
carboxypeptidase E |
|
decreases expression |
EXP |
4 |
166,300,097 |
166,419,482 |
RGD:6480464 |
CTD |
| G |
CRADD |
CASP2 and RIPK1 domain containing adaptor with death domain |
|
decreases expression |
EXP |
12 |
94,071,151 |
94,244,532 |
RGD:6480464 |
CTD |
| G |
CREB1 |
cAMP responsive element binding protein 1 |
|
multiple interactions |
ISO |
2 |
208,394,616 |
208,470,284 |
RGD:6480464 |
CTD |
| G |
CSF2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
multiple interactions |
EXP |
5 |
131,409,485 |
131,411,863 |
RGD:6480464 |
CTD |
| G |
CTGF |
connective tissue growth factor |
|
multiple interactions |
ISO |
6 |
132,269,316 |
132,272,518 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
multiple interactions |
ISO |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
|
multiple interactions |
EXP |
3 |
41,240,942 |
41,281,939 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
decreases expression |
EXP |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
4 |
74,735,109 |
74,737,019 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
EXP |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CXCL2 |
chemokine (C-X-C motif) ligand 2 |
|
multiple interactions |
ISO |
4 |
74,962,752 |
74,964,997 |
RGD:6480464 |
CTD |
| G |
CYBA |
cytochrome b-245, alpha polypeptide |
|
multiple interactions |
ISO |
16 |
88,709,697 |
88,717,492 |
RGD:6480464 |
CTD |
| G |
CYBB |
cytochrome b-245, beta polypeptide |
|
multiple interactions |
ISO |
X |
37,639,270 |
37,672,714 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
multiple interactions |
EXP |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
multiple interactions |
ISO |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYCS |
cytochrome c, somatic |
|
multiple interactions |
EXP |
7 |
25,158,270 |
25,164,980 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
EXP |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A1 |
cytochrome P450, family 1, subfamily A, polypeptide 1 |
|
multiple interactions |
ISO |
15 |
75,011,883 |
75,017,877 |
RGD:6480464 |
CTD |
| G |
CYP1A2 |
cytochrome P450, family 1, subfamily A, polypeptide 2 |
|
multiple interactions |
ISO |
15 |
75,041,184 |
75,048,941 |
RGD:6480464 |
CTD |
| G |
CYP1B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 |
|
multiple interactions |
EXP |
2 |
38,294,746 |
38,303,323 |
RGD:6480464 |
CTD |
| G |
CYP2E1 |
cytochrome P450, family 2, subfamily E, polypeptide 1 |
|
multiple interactions |
ISO |
10 |
135,340,867 |
135,352,620 |
RGD:6480464 |
CTD |
| G |
CYP4A11 |
cytochrome P450, family 4, subfamily A, polypeptide 11 |
|
multiple interactions |
EXP |
1 |
47,394,846 |
47,407,156 |
RGD:6480464 |
CTD |
| G |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
|
multiple interactions |
EXP |
1 |
86,046,444 |
86,049,650 |
RGD:6480464 |
CTD |
| G |
CYR61 |
cysteine-rich, angiogenic inducer, 61 |
|
increases expression |
EXP |
1 |
86,046,444 |
86,049,650 |
RGD:6480464 |
CTD |
| G |
DAPK1 |
death-associated protein kinase 1 |
|
multiple interactions |
ISO |
9 |
90,112,756 |
90,323,549 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
increases expression |
EXP |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DDIT3 |
DNA-damage-inducible transcript 3 |
|
multiple interactions |
ISO |
12 |
57,910,371 |
57,914,300 |
RGD:6480464 |
CTD |
| G |
DIO2 |
deiodinase, iodothyronine, type II |
|
multiple interactions |
ISO |
14 |
80,663,868 |
80,697,397 |
RGD:6480464 |
CTD |
| G |
DIO3 |
deiodinase, iodothyronine, type III |
|
multiple interactions |
ISO |
14 |
102,027,688 |
102,029,789 |
RGD:6480464 |
CTD |
| G |
DNAJB1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 |
|
multiple interactions |
EXP |
19 |
14,625,582 |
14,629,201 |
RGD:6480464 |
CTD |
| G |
DNAJB4 |
DnaJ (Hsp40) homolog, subfamily B, member 4 |
|
multiple interactions |
EXP |
1 |
78,470,636 |
78,482,998 |
RGD:6480464 |
CTD |
| G |
DNAJB9 |
DnaJ (Hsp40) homolog, subfamily B, member 9 |
|
increases expression |
EXP |
7 |
108,210,189 |
108,215,294 |
RGD:6480464 |
CTD |
| G |
DSPP |
dentin sialophosphoprotein |
|
increases expression |
EXP |
4 |
88,529,681 |
88,538,025 |
RGD:6480464 |
CTD |
| G |
DUSP4 |
dual specificity phosphatase 4 |
|
increases expression |
EXP |
8 |
29,190,579 |
29,208,267 |
RGD:6480464 |
CTD |
| G |
DUT |
deoxyuridine triphosphatase |
|
multiple interactions |
EXP |
15 |
48,623,621 |
48,635,570 |
RGD:6480464 |
CTD |
| G |
E2F1 |
E2F transcription factor 1 |
|
multiple interactions |
EXP |
20 |
32,263,292 |
32,274,210 |
RGD:6480464 |
CTD |
| G |
EDN1 |
endothelin 1 |
|
multiple interactions |
ISO |
6 |
12,290,529 |
12,297,427 |
RGD:6480464 |
CTD |
| G |
EFNB2 |
ephrin-B2 |
|
decreases expression |
EXP |
13 |
107,142,079 |
107,187,388 |
RGD:6480464 |
CTD |
| G |
EGF |
epidermal growth factor |
|
multiple interactions |
ISO |
4 |
110,834,040 |
110,934,118 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
EXP |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGFR |
epidermal growth factor receptor |
|
multiple interactions |
ISO |
7 |
55,086,725 |
55,275,031 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
multiple interactions |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR1 |
early growth response 1 |
|
multiple interactions |
ISO |
5 |
137,801,181 |
137,805,004 |
RGD:6480464 |
CTD |
| G |
EGR2 |
early growth response 2 |
|
multiple interactions |
EXP |
10 |
64,571,756 |
64,578,927 |
RGD:6480464 |
CTD |
| G |
EI24 |
etoposide induced 2.4 |
|
multiple interactions |
ISO |
11 |
125,439,298 |
125,454,575 |
RGD:6480464 |
CTD |
| G |
EIF2A |
eukaryotic translation initiation factor 2A, 65kDa |
|
multiple interactions |
ISO |
3 |
150,264,574 |
150,303,803 |
RGD:6480464 |
CTD |
| G |
EIF2AK3 |
eukaryotic translation initiation factor 2-alpha kinase 3 |
|
multiple interactions |
EXP |
2 |
88,856,259 |
88,927,094 |
RGD:6480464 |
CTD |
| G |
EIF2S1 |
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
|
multiple interactions |
EXP |
14 |
67,827,034 |
67,853,233 |
RGD:6480464 |
CTD |
| G |
EIF2S1 |
eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa |
|
multiple interactions |
ISO |
14 |
67,827,034 |
67,853,233 |
RGD:6480464 |
CTD |
| G |
EIF4EBP1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
multiple interactions |
ISO |
8 |
37,888,020 |
37,917,883 |
RGD:6480464 |
CTD |
| G |
ENDOG |
endonuclease G |
|
multiple interactions |
EXP |
9 |
131,580,779 |
131,584,955 |
RGD:6480464 |
CTD |
| G |
ENDOG |
endonuclease G |
|
multiple interactions |
EXP |
9 |
131,580,779 |
131,584,955 |
RGD:6480464 |
CTD |
| G |
EP300 |
E1A binding protein p300 |
|
multiple interactions |
EXP |
22 |
41,488,614 |
41,576,081 |
RGD:6480464 |
CTD |
| G |
EPB41 |
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
|
multiple interactions |
ISO |
1 |
29,213,603 |
29,446,558 |
RGD:6480464 |
CTD |
| G |
ERN1 |
endoplasmic reticulum to nucleus signaling 1 |
|
multiple interactions |
ISO |
17 |
62,120,390 |
62,207,502 |
RGD:6480464 |
CTD |
| G |
ESR1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
6 |
152,011,631 |
152,424,409 |
RGD:6480464 |
CTD |
| G |
ESR2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
EXP |
14 |
64,693,751 |
64,805,268 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
ISO |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
ISO |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FAS |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
10 |
90,750,288 |
90,775,542 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
ISO |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FASLG |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
172,628,185 |
172,636,013 |
RGD:6480464 |
CTD |
| G |
FGF2 |
fibroblast growth factor 2 (basic) |
|
decreases expression |
EXP |
4 |
123,747,863 |
123,819,390 |
RGD:6480464 |
CTD |
| G |
FGF2 |
fibroblast growth factor 2 (basic) |
|
multiple interactions |
EXP |
4 |
123,747,863 |
123,819,390 |
RGD:6480464 |
CTD |
| G |
FHIT |
fragile histidine triad |
|
multiple interactions |
ISO |
3 |
59,735,036 |
61,237,133 |
RGD:6480464 |
CTD |
| G |
FILIP1L |
filamin A interacting protein 1-like |
|
decreases expression |
EXP |
3 |
99,551,988 |
99,833,349 |
RGD:6480464 |
CTD |
| G |
FKBP5 |
FK506 binding protein 5 |
|
multiple interactions |
EXP |
6 |
35,541,362 |
35,696,360 |
RGD:6480464 |
CTD |
| G |
FLT1 |
fms-related tyrosine kinase 1 |
|
increases expression |
EXP |
13 |
28,874,483 |
29,069,265 |
RGD:6480464 |
CTD |
| G |
FN1 |
fibronectin 1 |
|
multiple interactions |
ISO |
2 |
216,225,177 |
216,300,791 |
RGD:6480464 |
CTD |
| G |
FN1 |
fibronectin 1 |
|
multiple interactions |
EXP |
2 |
216,225,177 |
216,300,791 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOS |
FBJ murine osteosarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
75,745,481 |
75,748,937 |
RGD:6480464 |
CTD |
| G |
FOSL1 |
FOS-like antigen 1 |
|
multiple interactions |
ISO |
11 |
65,659,692 |
65,667,997 |
RGD:6480464 |
CTD |
| G |
FOSL1 |
FOS-like antigen 1 |
|
multiple interactions |
ISO |
11 |
65,659,692 |
65,667,997 |
RGD:6480464 |
CTD |
| G |
FTH1 |
ferritin, heavy polypeptide 1 |
|
multiple interactions |
ISO |
11 |
61,731,757 |
61,735,132 |
RGD:6480464 |
CTD |
| G |
FXN |
frataxin |
|
affects response to substance |
ISO |
9 |
71,650,479 |
71,715,094 |
RGD:6480464 |
CTD |
| G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
ISO |
X |
153,759,606 |
153,775,787 |
RGD:6480464 |
CTD |
| G |
G6PD |
glucose-6-phosphate dehydrogenase |
|
multiple interactions |
ISO |
X |
153,759,606 |
153,775,787 |
RGD:6480464 |
CTD |
| G |
GADD45A |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
EXP |
1 |
68,150,860 |
68,154,021 |
RGD:6480464 |
CTD |
| G |
GAPDH |
glyceraldehyde-3-phosphate dehydrogenase |
|
decreases expression |
ISO |
12 |
6,643,585 |
6,647,537 |
RGD:6480464 |
CTD |
| G |
GATA1 |
GATA binding protein 1 (globin transcription factor 1) |
|
multiple interactions |
EXP |
X |
48,644,982 |
48,652,718 |
RGD:6480464 |
CTD |
| G |
GBP1 |
guanylate binding protein 1, interferon-inducible |
|
decreases expression |
EXP |
1 |
89,517,987 |
89,531,043 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
ISO |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLC |
glutamate-cysteine ligase, catalytic subunit |
|
multiple interactions |
EXP |
6 |
53,362,139 |
53,409,927 |
RGD:6480464 |
CTD |
| G |
GCLM |
glutamate-cysteine ligase, modifier subunit |
|
multiple interactions |
EXP |
1 |
94,352,590 |
94,375,012 |
RGD:6480464 |
CTD |
| G |
GCLM |
glutamate-cysteine ligase, modifier subunit |
|
multiple interactions |
EXP |
1 |
94,352,590 |
94,375,012 |
RGD:6480464 |
CTD |
| G |
GCLM |
glutamate-cysteine ligase, modifier subunit |
|
multiple interactions |
ISO |
1 |
94,352,590 |
94,375,012 |
RGD:6480464 |
CTD |
| G |
GGT1 |
gamma-glutamyltransferase 1 |
|
multiple interactions |
ISO |
22 |
24,979,718 |
25,024,972 |
RGD:6480464 |
CTD |
| G |
GJA4 |
gap junction protein, alpha 4, 37kDa |
|
decreases expression |
EXP |
1 |
35,258,599 |
35,261,348 |
RGD:6480464 |
CTD |
| G |
GLCCI1 |
glucocorticoid induced transcript 1 |
|
multiple interactions |
ISO |
7 |
8,008,374 |
8,128,710 |
RGD:6480464 |
CTD |
| G |
GLRX |
glutaredoxin (thioltransferase) |
|
affects response to substance |
EXP |
5 |
95,149,553 |
95,158,577 |
RGD:6480464 |
CTD |
| G |
GRM2 |
glutamate receptor, metabotropic 2 |
|
increases activity |
EXP |
3 |
51,741,081 |
51,752,629 |
RGD:6480464 |
CTD |
| G |
GRM3 |
glutamate receptor, metabotropic 3 |
|
increases activity |
EXP |
7 |
86,273,230 |
86,494,192 |
RGD:6480464 |
CTD |
| G |
GRM5 |
glutamate receptor, metabotropic 5 |
|
increases activity |
EXP |
11 |
88,237,744 |
88,796,816 |
RGD:6480464 |
CTD |
| G |
GSK3B |
glycogen synthase kinase 3 beta |
|
multiple interactions |
ISO |
3 |
119,540,800 |
119,813,264 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
EXP |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSR |
glutathione reductase |
|
multiple interactions |
ISO |
8 |
30,535,578 |
30,585,486 |
RGD:6480464 |
CTD |
| G |
GSTM1 |
glutathione S-transferase mu 1 |
|
multiple interactions |
EXP |
1 |
110,230,418 |
110,236,367 |
RGD:6480464 |
CTD |
| G |
GULP1 |
GULP, engulfment adaptor PTB domain containing 1 |
|
decreases expression |
EXP |
2 |
189,156,396 |
189,460,653 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
H2AFX |
H2A histone family, member X |
|
multiple interactions |
EXP |
11 |
118,964,584 |
118,966,177 |
RGD:6480464 |
CTD |
| G |
HAX1 |
HCLS1 associated protein X-1 |
|
multiple interactions |
EXP |
1 |
154,245,039 |
154,248,351 |
RGD:6480464 |
CTD |
| G |
HBEGF |
heparin-binding EGF-like growth factor |
|
multiple interactions |
EXP |
5 |
139,712,428 |
139,726,188 |
RGD:6480464 |
CTD |
| G |
HERPUD1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
increases expression |
EXP |
16 |
56,965,748 |
56,977,793 |
RGD:6480464 |
CTD |
| G |
HERPUD1 |
homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1 |
|
multiple interactions |
EXP |
16 |
56,965,748 |
56,977,793 |
RGD:6480464 |
CTD |
| G |
HGF |
hepatocyte growth factor (hepapoietin A; scatter factor) |
|
multiple interactions |
EXP |
7 |
81,331,444 |
81,399,452 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
EXP |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HIF1A |
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
multiple interactions |
ISO |
14 |
62,162,119 |
62,214,977 |
RGD:6480464 |
CTD |
| G |
HK2 |
hexokinase 2 |
|
increases expression |
EXP |
2 |
75,059,782 |
75,120,481 |
RGD:6480464 |
CTD |
| G |
HMBS |
hydroxymethylbilane synthase |
|
multiple interactions |
EXP |
11 |
118,955,587 |
118,964,259 |
RGD:6480464 |
CTD |
| G |
HMGCR |
3-hydroxy-3-methylglutaryl-CoA reductase |
|
multiple interactions |
ISO |
5 |
74,632,993 |
74,657,926 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
affects activity |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
increases expression |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HMOX1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
EXP |
22 |
35,777,060 |
35,790,207 |
RGD:6480464 |
CTD |
| G |
HRAS |
v-Ha-ras Harvey rat sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
11 |
532,242 |
535,550 |
RGD:6480464 |
CTD |
| G |
HSBP1 |
heat shock factor binding protein 1 |
|
multiple interactions |
ISO |
16 |
83,841,508 |
83,846,607 |
RGD:6480464 |
CTD |
| G |
HSD11B2 |
hydroxysteroid (11-beta) dehydrogenase 2 |
|
multiple interactions |
EXP |
16 |
67,465,036 |
67,471,456 |
RGD:6480464 |
CTD |
| G |
HSD17B8 |
hydroxysteroid (17-beta) dehydrogenase 8 |
|
multiple interactions |
EXP |
6 |
33,172,414 |
33,174,608 |
RGD:6480464 |
CTD |
| G |
HSP90B1 |
heat shock protein 90kDa beta (Grp94), member 1 |
|
multiple interactions |
ISO |
12 |
104,324,112 |
104,341,708 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
multiple interactions |
EXP |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
multiple interactions |
EXP |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPA1A |
heat shock 70kDa protein 1A |
|
multiple interactions |
EXP |
6 |
31,783,291 |
31,785,719 |
RGD:6480464 |
CTD |
| G |
HSPA1B |
heat shock 70kDa protein 1B |
|
multiple interactions |
EXP |
6 |
31,795,512 |
31,798,031 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
increases expression |
EXP |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions |
ISO |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions |
ISO |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HSPA5 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) |
|
multiple interactions |
ISO |
9 |
127,997,127 |
128,003,666 |
RGD:6480464 |
CTD |
| G |
HTATIP2 |
HIV-1 Tat interactive protein 2, 30kDa |
|
decreases expression |
EXP |
11 |
20,385,231 |
20,405,329 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
EXP |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
affects expression |
EXP |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
decreases expression |
ISO |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ICAM1 |
intercellular adhesion molecule 1 |
|
multiple interactions |
ISO |
19 |
10,381,517 |
10,397,291 |
RGD:6480464 |
CTD |
| G |
ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
|
decreases expression |
EXP |
2 |
8,822,113 |
8,824,583 |
RGD:6480464 |
CTD |
| G |
IER5 |
immediate early response 5 |
|
multiple interactions |
EXP |
1 |
181,057,638 |
181,059,979 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
EXP |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFNG |
interferon, gamma |
|
multiple interactions |
ISO |
12 |
68,548,550 |
68,553,521 |
RGD:6480464 |
CTD |
| G |
IFRD1 |
interferon-related developmental regulator 1 |
|
multiple interactions |
EXP |
7 |
112,063,199 |
112,117,258 |
RGD:6480464 |
CTD |
| G |
IGF1R |
insulin-like growth factor 1 receptor |
|
multiple interactions |
ISO |
15 |
99,192,761 |
99,507,759 |
RGD:6480464 |
CTD |
| G |
IKBKB |
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta |
|
decreases activity |
EXP |
8 |
42,128,820 |
42,190,171 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
EXP |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10 |
interleukin 10 |
|
multiple interactions |
ISO |
1 |
206,940,948 |
206,945,839 |
RGD:6480464 |
CTD |
| G |
IL10RB |
interleukin 10 receptor, beta |
|
decreases expression |
EXP |
21 |
34,638,665 |
34,669,539 |
RGD:6480464 |
CTD |
| G |
IL12A |
interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
|
multiple interactions |
ISO |
3 |
159,706,623 |
159,713,806 |
RGD:6480464 |
CTD |
| G |
IL12B |
interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
|
multiple interactions |
ISO |
5 |
158,741,791 |
158,757,481 |
RGD:6480464 |
CTD |
| G |
IL17A |
interleukin 17A |
|
multiple interactions |
ISO |
6 |
52,051,185 |
52,055,436 |
RGD:6480464 |
CTD |
| G |
IL17A |
interleukin 17A |
|
multiple interactions |
ISO |
6 |
52,051,185 |
52,055,436 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
affects expression |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
ISO |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL1B |
interleukin 1, beta |
|
multiple interactions |
EXP |
2 |
113,587,337 |
113,594,356 |
RGD:6480464 |
CTD |
| G |
IL2 |
interleukin 2 |
|
multiple interactions |
EXP |
4 |
123,372,625 |
123,377,650 |
RGD:6480464 |
CTD |
| G |
IL24 |
interleukin 24 |
|
decreases activity |
EXP |
1 |
207,070,788 |
207,077,484 |
RGD:6480464 |
CTD |
| G |
IL27RA |
interleukin 27 receptor, alpha |
|
decreases expression |
EXP |
19 |
14,142,552 |
14,163,731 |
RGD:6480464 |
CTD |
| G |
IL5 |
interleukin 5 (colony-stimulating factor, eosinophil) |
|
multiple interactions |
ISO |
5 |
131,877,136 |
131,879,214 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
ISO |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL6 |
interleukin 6 (interferon, beta 2) |
|
multiple interactions |
EXP |
7 |
22,766,766 |
22,771,621 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
multiple interactions |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
IL8 |
interleukin 8 |
|
decreases expression |
EXP |
4 |
74,606,223 |
74,609,433 |
RGD:6480464 |
CTD |
| G |
INS |
insulin |
|
multiple interactions |
EXP |
11 |
2,181,009 |
2,182,439 |
RGD:6480464 |
CTD |
| G |
INS |
insulin |
|
multiple interactions |
ISO |
11 |
2,181,009 |
2,182,439 |
RGD:6480464 |
CTD |
| G |
IRF1 |
interferon regulatory factor 1 |
|
multiple interactions |
EXP |
5 |
131,817,301 |
131,826,465 |
RGD:6480464 |
CTD |
| G |
ITGAV |
integrin, alpha V |
|
decreases expression |
EXP |
2 |
187,454,790 |
187,545,628 |
RGD:6480464 |
CTD |
| G |
JAG1 |
jagged 1 |
|
decreases expression |
EXP |
20 |
10,618,332 |
10,654,694 |
RGD:6480464 |
CTD |
| G |
JAK2 |
Janus kinase 2 |
|
multiple interactions |
ISO |
9 |
4,985,245 |
5,128,183 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
decreases activity |
EXP |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUN |
jun proto-oncogene |
|
multiple interactions |
ISO |
1 |
59,246,463 |
59,249,785 |
RGD:6480464 |
CTD |
| G |
JUNB |
jun B proto-oncogene |
|
multiple interactions |
ISO |
19 |
12,902,310 |
12,904,125 |
RGD:6480464 |
CTD |
| G |
KDR |
kinase insert domain receptor (a type III receptor tyrosine kinase) |
|
increases expression |
EXP |
4 |
55,944,426 |
55,991,762 |
RGD:6480464 |
CTD |
| G |
KEAP1 |
kelch-like ECH-associated protein 1 |
|
multiple interactions |
EXP |
19 |
10,596,796 |
10,614,054 |
RGD:6480464 |
CTD |
| G |
KEAP1 |
kelch-like ECH-associated protein 1 |
|
multiple interactions |
EXP |
19 |
10,596,796 |
10,614,054 |
RGD:6480464 |
CTD |
| G |
KLK3 |
kallikrein-related peptidase 3 |
|
multiple interactions |
EXP |
19 |
51,358,171 |
51,364,020 |
RGD:6480464 |
CTD |
| G |
KRAS |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
12 |
25,358,180 |
25,403,854 |
RGD:6480464 |
CTD |
| G |
KRT6A |
keratin 6A |
|
multiple interactions |
EXP |
12 |
52,880,958 |
52,887,181 |
RGD:6480464 |
CTD |
| G |
KRT8 |
keratin 8 |
|
multiple interactions |
EXP |
12 |
53,290,971 |
53,343,650 |
RGD:6480464 |
CTD |
| G |
MALAT1 |
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
|
multiple interactions |
EXP |
11 |
65,265,233 |
65,273,940 |
RGD:6480464 |
CTD |
| G |
MAP1LC3B |
microtubule-associated protein 1 light chain 3 beta |
|
multiple interactions |
EXP |
16 |
87,425,801 |
87,438,380 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K1 |
mitogen-activated protein kinase kinase 1 |
|
multiple interactions |
ISO |
15 |
66,679,211 |
66,783,882 |
RGD:6480464 |
CTD |
| G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
|
multiple interactions |
EXP |
19 |
4,090,319 |
4,124,126 |
RGD:6480464 |
CTD |
| G |
MAP2K2 |
mitogen-activated protein kinase kinase 2 |
|
multiple interactions |
ISO |
19 |
4,090,319 |
4,124,126 |
RGD:6480464 |
CTD |
| G |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
|
multiple interactions |
ISO |
17 |
21,187,968 |
21,218,552 |
RGD:6480464 |
CTD |
| G |
MAP2K3 |
mitogen-activated protein kinase kinase 3 |
|
multiple interactions |
EXP |
17 |
21,187,968 |
21,218,552 |
RGD:6480464 |
CTD |
| G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
|
multiple interactions |
EXP |
17 |
11,924,135 |
12,047,051 |
RGD:6480464 |
CTD |
| G |
MAP2K4 |
mitogen-activated protein kinase kinase 4 |
|
multiple interactions |
ISO |
17 |
11,924,135 |
12,047,051 |
RGD:6480464 |
CTD |
| G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
|
multiple interactions |
EXP |
17 |
67,410,838 |
67,538,470 |
RGD:6480464 |
CTD |
| G |
MAP2K6 |
mitogen-activated protein kinase kinase 6 |
|
multiple interactions |
ISO |
17 |
67,410,838 |
67,538,470 |
RGD:6480464 |
CTD |
| G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
6 |
136,878,187 |
137,113,656 |
RGD:6480464 |
CTD |
| G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
6 |
136,878,187 |
137,113,656 |
RGD:6480464 |
CTD |
| G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
6 |
136,878,187 |
137,113,656 |
RGD:6480464 |
CTD |
| G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
EXP |
6 |
136,878,187 |
137,113,656 |
RGD:6480464 |
CTD |
| G |
MAP3K5 |
mitogen-activated protein kinase kinase kinase 5 |
|
multiple interactions |
ISO |
6 |
136,878,187 |
137,113,656 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
decreases phosphorylation |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
increases phosphorylation |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
ISO |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK1 |
mitogen-activated protein kinase 1 |
|
multiple interactions |
EXP |
22 |
22,113,946 |
22,221,970 |
RGD:6480464 |
CTD |
| G |
MAPK10 |
mitogen-activated protein kinase 10 |
|
multiple interactions |
EXP |
4 |
86,936,276 |
87,374,283 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
EXP |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK14 |
mitogen-activated protein kinase 14 |
|
multiple interactions |
ISO |
6 |
35,995,454 |
36,079,013 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
decreases phosphorylation |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
increases phosphorylation |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
ISO |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK3 |
mitogen-activated protein kinase 3 |
|
multiple interactions |
EXP |
16 |
30,125,426 |
30,134,630 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
EXP |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
10 |
49,609,687 |
49,643,183 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
EXP |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MAPK9 |
mitogen-activated protein kinase 9 |
|
multiple interactions |
ISO |
5 |
179,660,594 |
179,719,071 |
RGD:6480464 |
CTD |
| G |
MCL1 |
myeloid cell leukemia sequence 1 (BCL2-related) |
|
multiple interactions |
EXP |
1 |
150,547,027 |
150,552,214 |
RGD:6480464 |
CTD |
| G |
MCL1 |
myeloid cell leukemia sequence 1 (BCL2-related) |
|
multiple interactions |
ISO |
1 |
150,547,027 |
150,552,214 |
RGD:6480464 |
CTD |
| G |
MGEA5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
decreases expression |
EXP |
10 |
103,544,200 |
103,578,222 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
EXP |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
decreases activity |
EXP |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MGMT |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
10 |
131,265,454 |
131,565,783 |
RGD:6480464 |
CTD |
| G |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
|
multiple interactions |
EXP |
11 |
102,660,641 |
102,668,966 |
RGD:6480464 |
CTD |
| G |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
multiple interactions |
ISO |
16 |
55,513,081 |
55,540,586 |
RGD:6480464 |
CTD |
| G |
MMP2 |
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
|
decreases activity |
ISO |
16 |
55,513,081 |
55,540,586 |
RGD:6480464 |
CTD |
| G |
MMP7 |
matrix metallopeptidase 7 (matrilysin, uterine) |
|
multiple interactions |
EXP |
11 |
102,391,239 |
102,401,478 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
multiple interactions |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
decreases activity |
ISO |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MMP9 |
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
|
decreases activity |
EXP |
20 |
44,637,547 |
44,645,200 |
RGD:6480464 |
CTD |
| G |
MOAP1 |
modulator of apoptosis 1 |
|
decreases expression |
EXP |
14 |
93,648,541 |
93,651,249 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MPO |
myeloperoxidase |
|
multiple interactions |
ISO |
17 |
56,347,217 |
56,358,296 |
RGD:6480464 |
CTD |
| G |
MSTN |
myostatin |
|
decreases expression |
ISO |
2 |
190,920,426 |
190,927,455 |
RGD:6480464 |
CTD |
| G |
MT1A |
metallothionein 1A |
|
multiple interactions |
ISO |
16 |
56,672,578 |
56,673,999 |
RGD:6480464 |
CTD |
| G |
MT1E |
metallothionein 1E |
|
multiple interactions |
EXP |
16 |
56,659,585 |
56,661,024 |
RGD:6480464 |
CTD |
| G |
MT1F |
metallothionein 1F |
|
multiple interactions |
EXP |
16 |
56,691,855 |
56,693,215 |
RGD:6480464 |
CTD |
| G |
MT1G |
metallothionein 1G |
|
multiple interactions |
EXP |
16 |
56,700,653 |
56,701,977 |
RGD:6480464 |
CTD |
| G |
MT1H |
metallothionein 1H |
|
multiple interactions |
EXP |
16 |
56,703,726 |
56,705,041 |
RGD:6480464 |
CTD |
| G |
MT1M |
metallothionein 1M |
|
multiple interactions |
EXP |
16 |
56,666,534 |
56,667,898 |
RGD:6480464 |
CTD |
| G |
MT1X |
metallothionein 1X |
|
multiple interactions |
EXP |
16 |
56,716,382 |
56,718,108 |
RGD:6480464 |
CTD |
| G |
MT1X |
metallothionein 1X |
|
multiple interactions |
EXP |
16 |
56,716,382 |
56,718,108 |
RGD:6480464 |
CTD |
| G |
MT2A |
metallothionein 2A |
|
multiple interactions |
EXP |
16 |
56,642,478 |
56,643,409 |
RGD:6480464 |
CTD |
| G |
MT2A |
metallothionein 2A |
|
multiple interactions |
EXP |
16 |
56,642,478 |
56,643,409 |
RGD:6480464 |
CTD |
| G |
MT2A |
metallothionein 2A |
|
multiple interactions |
ISO |
16 |
56,642,478 |
56,643,409 |
RGD:6480464 |
CTD |
| G |
MTOR |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
1 |
11,166,588 |
11,322,608 |
RGD:6480464 |
CTD |
| G |
MUC5AC |
mucin 5AC, oligomeric mucus/gel-forming |
|
multiple interactions |
EXP |
11 |
1,142,474 |
1,162,465 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
MYC |
v-myc myelocytomatosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
8 |
128,748,315 |
128,753,680 |
RGD:6480464 |
CTD |
| G |
NBN |
nibrin |
|
multiple interactions |
EXP |
8 |
90,945,564 |
90,996,899 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
multiple interactions |
ISO |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF1 |
neutrophil cytosolic factor 1 |
|
decreases expression |
ISO |
7 |
74,188,309 |
74,203,659 |
RGD:6480464 |
CTD |
| G |
NCF2 |
neutrophil cytosolic factor 2 |
|
decreases expression |
ISO |
1 |
183,524,697 |
183,560,056 |
RGD:6480464 |
CTD |
| G |
NCF2 |
neutrophil cytosolic factor 2 |
|
multiple interactions |
ISO |
1 |
183,524,697 |
183,560,056 |
RGD:6480464 |
CTD |
| G |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
|
multiple interactions |
ISO |
22 |
37,257,030 |
37,274,059 |
RGD:6480464 |
CTD |
| G |
NCF4 |
neutrophil cytosolic factor 4, 40kDa |
|
decreases expression |
ISO |
22 |
37,257,030 |
37,274,059 |
RGD:6480464 |
CTD |
| G |
NDUFB6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa |
|
multiple interactions |
EXP |
9 |
32,553,524 |
32,573,182 |
RGD:6480464 |
CTD |
| G |
NDUFB6 |
NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa |
|
increases expression |
EXP |
9 |
32,553,524 |
32,573,182 |
RGD:6480464 |
CTD |
| G |
NDUFS7 |
NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) |
|
increases expression |
EXP |
19 |
1,383,883 |
1,395,588 |
RGD:6480464 |
CTD |
| G |
NEDD9 |
neural precursor cell expressed, developmentally down-regulated 9 |
|
decreases expression |
EXP |
6 |
11,183,531 |
11,382,581 |
RGD:6480464 |
CTD |
| G |
NFE2 |
nuclear factor (erythroid-derived 2), 45kDa |
|
multiple interactions |
EXP |
12 |
54,685,891 |
54,694,821 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
ISO |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
ISO |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
affects localization |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
ISO |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFE2L2 |
nuclear factor (erythroid-derived 2)-like 2 |
|
multiple interactions |
EXP |
2 |
178,095,031 |
178,129,859 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
EXP |
4 |
103,422,486 |
103,538,459 |
RGD:6480464 |
CTD |
| G |
NFKB2 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) |
|
multiple interactions |
ISO |
10 |
104,153,867 |
104,162,286 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
affects expression |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases degradation |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIA |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
14 |
35,870,716 |
35,873,960 |
RGD:6480464 |
CTD |
| G |
NFKBIB |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, beta |
|
multiple interactions |
EXP |
19 |
39,390,340 |
39,399,534 |
RGD:6480464 |
CTD |
| G |
NGF |
nerve growth factor (beta polypeptide) |
|
multiple interactions |
ISO |
1 |
115,828,537 |
115,880,857 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
EXP |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS2 |
nitric oxide synthase 2, inducible |
|
multiple interactions |
ISO |
17 |
26,083,792 |
26,127,555 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions |
ISO |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
increases expression |
ISO |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NOS3 |
nitric oxide synthase 3 (endothelial cell) |
|
multiple interactions |
EXP |
7 |
150,688,144 |
150,711,687 |
RGD:6480464 |
CTD |
| G |
NOX1 |
NADPH oxidase 1 |
|
multiple interactions |
ISO |
X |
100,098,313 |
100,129,334 |
RGD:6480464 |
CTD |
| G |
NOX4 |
NADPH oxidase 4 |
|
multiple interactions |
ISO |
11 |
89,057,521 |
89,322,779 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
EXP |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NQO1 |
NAD(P)H dehydrogenase, quinone 1 |
|
multiple interactions |
ISO |
16 |
69,743,304 |
69,760,533 |
RGD:6480464 |
CTD |
| G |
NR3C1 |
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) |
|
decreases expression |
EXP |
5 |
142,657,496 |
142,815,077 |
RGD:6480464 |
CTD |
| G |
NTHL1 |
nth endonuclease III-like 1 (E. coli) |
|
multiple interactions |
ISO |
16 |
2,089,816 |
2,097,867 |
RGD:6480464 |
CTD |
| G |
OLR1 |
oxidized low density lipoprotein (lectin-like) receptor 1 |
|
multiple interactions |
ISO |
12 |
10,310,899 |
10,324,790 |
RGD:6480464 |
CTD |
| G |
P2RX2 |
purinergic receptor P2X, ligand-gated ion channel, 2 |
|
multiple interactions |
ISO |
12 |
133,195,403 |
133,198,972 |
RGD:6480464 |
CTD |
| G |
PARK7 |
parkinson protein 7 |
|
multiple interactions |
EXP |
1 |
8,021,714 |
8,045,342 |
RGD:6480464 |
CTD |
| G |
PARK7 |
parkinson protein 7 |
|
multiple interactions |
EXP |
1 |
8,021,714 |
8,045,342 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
increases cleavage |
ISO |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
EXP |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PARP1 |
poly (ADP-ribose) polymerase 1 |
|
multiple interactions |
ISO |
1 |
226,548,392 |
226,595,801 |
RGD:6480464 |
CTD |
| G |
PDK1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
multiple interactions |
EXP |
2 |
173,420,779 |
173,463,862 |
RGD:6480464 |
CTD |
| G |
PDLIM5 |
PDZ and LIM domain 5 |
|
decreases expression |
EXP |
4 |
95,373,008 |
95,589,378 |
RGD:6480464 |
CTD |
| G |
PGR |
progesterone receptor |
|
multiple interactions |
EXP |
11 |
100,900,355 |
101,000,544 |
RGD:6480464 |
CTD |
| G |
PIGA |
phosphatidylinositol glycan anchor biosynthesis, class A |
|
increases expression |
EXP |
X |
15,337,573 |
15,353,676 |
RGD:6480464 |
CTD |
| G |
PIM2 |
pim-2 oncogene |
|
increases expression |
EXP |
X |
48,770,459 |
48,776,413 |
RGD:6480464 |
CTD |
| G |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
multiple interactions |
ISO |
1 |
186,798,032 |
186,958,113 |
RGD:6480464 |
CTD |
| G |
PLAU |
plasminogen activator, urokinase |
|
decreases expression |
EXP |
10 |
75,670,862 |
75,677,259 |
RGD:6480464 |
CTD |
| G |
PLD1 |
phospholipase D1, phosphatidylcholine-specific |
|
multiple interactions |
EXP |
3 |
171,318,195 |
171,528,284 |
RGD:6480464 |
CTD |
| G |
PLD2 |
phospholipase D2 |
|
multiple interactions |
EXP |
17 |
4,710,396 |
4,726,727 |
RGD:6480464 |
CTD |
| G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
EXP |
18 |
57,567,192 |
57,571,538 |
RGD:6480464 |
CTD |
| G |
PMAIP1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
multiple interactions |
EXP |
18 |
57,567,192 |
57,571,538 |
RGD:6480464 |
CTD |
| G |
PON2 |
paraoxonase 2 |
|
multiple interactions |
EXP |
7 |
95,034,174 |
95,064,384 |
RGD:6480464 |
CTD |
| G |
PON2 |
paraoxonase 2 |
|
multiple interactions |
ISO |
7 |
95,034,174 |
95,064,384 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
increases expression |
ISO |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPARG |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
EXP |
3 |
12,329,349 |
12,475,855 |
RGD:6480464 |
CTD |
| G |
PPP2CA |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
EXP |
5 |
133,532,148 |
133,561,950 |
RGD:6480464 |
CTD |
| G |
PPP2CA |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
ISO |
5 |
133,532,148 |
133,561,950 |
RGD:6480464 |
CTD |
| G |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
|
multiple interactions |
EXP |
11 |
111,597,632 |
111,637,169 |
RGD:6480464 |
CTD |
| G |
PPP2R1B |
protein phosphatase 2, regulatory subunit A, beta |
|
multiple interactions |
ISO |
11 |
111,597,632 |
111,637,169 |
RGD:6480464 |
CTD |
| G |
PPP5C |
protein phosphatase 5, catalytic subunit |
|
multiple interactions |
ISO |
19 |
46,850,251 |
46,894,232 |
RGD:6480464 |
CTD |
| G |
PPP5C |
protein phosphatase 5, catalytic subunit |
|
multiple interactions |
EXP |
19 |
46,850,251 |
46,894,232 |
RGD:6480464 |
CTD |
| G |
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
ISO |
5 |
40,759,481 |
40,798,297 |
RGD:6480464 |
CTD |
| G |
PRKAA1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
multiple interactions |
EXP |
5 |
40,759,481 |
40,798,297 |
RGD:6480464 |
CTD |
| G |
PRKAA2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
multiple interactions |
ISO |
1 |
57,110,990 |
57,181,008 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKCD |
protein kinase C, delta |
|
multiple interactions |
EXP |
3 |
53,195,223 |
53,226,733 |
RGD:6480464 |
CTD |
| G |
PRKG1 |
protein kinase, cGMP-dependent, type I |
|
multiple interactions |
EXP |
10 |
52,750,911 |
54,058,110 |
RGD:6480464 |
CTD |
| G |
PSME4 |
proteasome (prosome, macropain) activator subunit 4 |
|
multiple interactions |
EXP |
2 |
54,091,204 |
54,197,977 |
RGD:6480464 |
CTD |
| G |
PTEN |
phosphatase and tensin homolog |
|
multiple interactions |
EXP |
10 |
89,623,195 |
89,728,532 |
RGD:6480464 |
CTD |
| G |
PTEN |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
10 |
89,623,195 |
89,728,532 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
decreases expression |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
ISO |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
PTGS2 |
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
|
multiple interactions |
EXP |
1 |
186,640,944 |
186,649,559 |
RGD:6480464 |
CTD |
| G |
RAB24 |
RAB24, member RAS oncogene family |
|
multiple interactions |
ISO |
5 |
176,728,199 |
176,730,744 |
RGD:6480464 |
CTD |
| G |
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
multiple interactions |
ISO |
7 |
6,414,126 |
6,443,598 |
RGD:6480464 |
CTD |
| G |
RAC1 |
ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
|
decreases expression |
ISO |
7 |
6,414,126 |
6,443,598 |
RGD:6480464 |
CTD |
| G |
RAF1 |
v-raf-1 murine leukemia viral oncogene homolog 1 |
|
multiple interactions |
ISO |
3 |
12,625,100 |
12,705,700 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
RB1 |
retinoblastoma 1 |
|
multiple interactions |
EXP |
13 |
48,877,883 |
49,056,026 |
RGD:6480464 |
CTD |
| G |
REL |
v-rel reticuloendotheliosis viral oncogene homolog (avian) |
|
multiple interactions |
ISO |
2 |
61,108,752 |
61,150,178 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases glutathionylation |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELA |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
EXP |
11 |
65,421,067 |
65,430,443 |
RGD:6480464 |
CTD |
| G |
RELB |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
19 |
45,504,707 |
45,541,456 |
RGD:6480464 |
CTD |
| G |
RELB |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
19 |
45,504,707 |
45,541,456 |
RGD:6480464 |
CTD |
| G |
RELB |
v-rel reticuloendotheliosis viral oncogene homolog B |
|
multiple interactions |
ISO |
19 |
45,504,707 |
45,541,456 |
RGD:6480464 |
CTD |
| G |
REN |
renin |
|
multiple interactions |
ISO |
1 |
204,123,944 |
204,135,465 |
RGD:6480464 |
CTD |
| G |
RHOBTB1 |
Rho-related BTB domain containing 1 |
|
decreases expression |
EXP |
10 |
62,629,196 |
62,761,198 |
RGD:6480464 |
CTD |
| G |
RIPK2 |
receptor-interacting serine-threonine kinase 2 |
|
multiple interactions |
ISO |
8 |
90,769,975 |
90,803,292 |
RGD:6480464 |
CTD |
| G |
RPS6KB1 |
ribosomal protein S6 kinase, 70kDa, polypeptide 1 |
|
multiple interactions |
ISO |
17 |
57,970,443 |
58,027,787 |
RGD:6480464 |
CTD |
| G |
RXRA |
retinoid X receptor, alpha |
|
multiple interactions |
EXP |
9 |
137,218,316 |
137,332,431 |
RGD:6480464 |
CTD |
| G |
SELE |
selectin E |
|
decreases expression |
EXP |
1 |
169,691,781 |
169,703,220 |
RGD:6480464 |
CTD |
| G |
SELE |
selectin E |
|
multiple interactions |
ISO |
1 |
169,691,781 |
169,703,220 |
RGD:6480464 |
CTD |
| G |
SERPINH1 |
serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1) |
|
multiple interactions |
EXP |
11 |
75,273,101 |
75,283,849 |
RGD:6480464 |
CTD |
| G |
SLC19A2 |
solute carrier family 19 (thiamine transporter), member 2 |
|
multiple interactions |
EXP |
1 |
169,433,147 |
169,455,208 |
RGD:6480464 |
CTD |
| G |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
multiple interactions |
ISO |
9 |
4,490,427 |
4,587,469 |
RGD:6480464 |
CTD |
| G |
SLC1A1 |
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
|
multiple interactions |
ISO |
9 |
4,490,427 |
4,587,469 |
RGD:6480464 |
CTD |
| G |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
|
multiple interactions |
ISO |
11 |
35,272,752 |
35,441,610 |
RGD:6480464 |
CTD |
| G |
SLC22A6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
EXP |
11 |
62,744,069 |
62,752,495 |
RGD:6480464 |
CTD |
| G |
SLC22A6 |
solute carrier family 22 (organic anion transporter), member 6 |
|
multiple interactions |
EXP |
11 |
62,744,069 |
62,752,495 |
RGD:6480464 |
CTD |
| G |
SLC22A8 |
solute carrier family 22 (organic anion transporter), member 8 |
|
multiple interactions |
ISO |
11 |
62,760,296 |
62,783,317 |
RGD:6480464 |
CTD |
| G |
SLC30A1 |
solute carrier family 30 (zinc transporter), member 1 |
|
multiple interactions |
EXP |
1 |
211,748,381 |
211,752,099 |
RGD:6480464 |
CTD |
| G |
SLC39A14 |
solute carrier family 39 (zinc transporter), member 14 |
|
increases expression |
EXP |
8 |
22,224,762 |
22,291,642 |
RGD:6480464 |
CTD |
| G |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
ISO |
4 |
139,085,248 |
139,163,503 |
RGD:6480464 |
CTD |
| G |
SLC7A11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
multiple interactions |
EXP |
4 |
139,085,248 |
139,163,503 |
RGD:6480464 |
CTD |
| G |
SMC1A |
structural maintenance of chromosomes 1A |
|
multiple interactions |
EXP |
X |
53,401,070 |
53,449,618 |
RGD:6480464 |
CTD |
| G |
SNAI1 |
snail homolog 1 (Drosophila) |
|
multiple interactions |
EXP |
20 |
48,599,513 |
48,605,423 |
RGD:6480464 |
CTD |
| G |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
|
multiple interactions |
EXP |
4 |
90,645,250 |
90,759,447 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
increases activity |
ISO |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
decreases expression |
ISO |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD1 |
superoxide dismutase 1, soluble |
|
multiple interactions |
EXP |
21 |
33,031,935 |
33,041,244 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
increases expression |
ISO |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SOD2 |
superoxide dismutase 2, mitochondrial |
|
multiple interactions |
EXP |
6 |
160,100,148 |
160,114,353 |
RGD:6480464 |
CTD |
| G |
SP1 |
Sp1 transcription factor |
|
decreases expression |
EXP |
12 |
53,773,979 |
53,810,230 |
RGD:6480464 |
CTD |
| G |
SP1 |
Sp1 transcription factor |
|
multiple interactions |
EXP |
12 |
53,773,979 |
53,810,230 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SPP1 |
secreted phosphoprotein 1 |
|
multiple interactions |
ISO |
4 |
88,896,802 |
88,904,563 |
RGD:6480464 |
CTD |
| G |
SRC |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
multiple interactions |
EXP |
20 |
35,973,088 |
36,033,821 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
ISO |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
ISO |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT1 |
signal transducer and activator of transcription 1, 91kDa |
|
multiple interactions |
EXP |
2 |
191,833,762 |
191,878,976 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
ISO |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
STAT3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
multiple interactions |
EXP |
17 |
40,465,343 |
40,540,513 |
RGD:6480464 |
CTD |
| G |
SYT7 |
synaptotagmin VII |
|
multiple interactions |
ISO |
11 |
61,281,188 |
61,348,344 |
RGD:6480464 |
CTD |
| G |
TALDO1 |
transaldolase 1 |
|
multiple interactions |
ISO |
11 |
747,432 |
765,024 |
RGD:6480464 |
CTD |
| G |
TANK |
TRAF family member-associated NFKB activator |
|
decreases expression |
EXP |
2 |
161,993,466 |
162,092,683 |
RGD:6480464 |
CTD |
| G |
TERT |
telomerase reverse transcriptase |
|
multiple interactions |
EXP |
5 |
1,253,282 |
1,295,162 |
RGD:6480464 |
CTD |
| G |
TERT |
telomerase reverse transcriptase |
|
multiple interactions |
ISO |
5 |
1,253,282 |
1,295,162 |
RGD:6480464 |
CTD |
| G |
TGFA |
transforming growth factor, alpha |
|
multiple interactions |
ISO |
2 |
70,674,412 |
70,781,147 |
RGD:6480464 |
CTD |
| G |
TGFB1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
19 |
41,836,812 |
41,859,831 |
RGD:6480464 |
CTD |
| G |
TGFBR1 |
transforming growth factor, beta receptor 1 |
|
decreases expression |
ISO |
9 |
101,867,412 |
101,916,474 |
RGD:6480464 |
CTD |
| G |
TGFBR1 |
transforming growth factor, beta receptor 1 |
|
multiple interactions |
ISO |
9 |
101,867,412 |
101,916,474 |
RGD:6480464 |
CTD |
| G |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
|
decreases expression |
ISO |
3 |
30,647,994 |
30,735,634 |
RGD:6480464 |
CTD |
| G |
TGFBR2 |
transforming growth factor, beta receptor II (70/80kDa) |
|
multiple interactions |
ISO |
3 |
30,647,994 |
30,735,634 |
RGD:6480464 |
CTD |
| G |
TLR4 |
toll-like receptor 4 |
|
multiple interactions |
ISO |
9 |
120,466,453 |
120,479,769 |
RGD:6480464 |
CTD |
| G |
TMPRSS2 |
transmembrane protease, serine 2 |
|
multiple interactions |
EXP |
21 |
42,836,478 |
42,880,085 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
affects expression |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
decreases expression |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
EXP |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNF |
tumor necrosis factor |
|
multiple interactions |
ISO |
6 |
31,543,344 |
31,546,113 |
RGD:6480464 |
CTD |
| G |
TNFAIP3 |
tumor necrosis factor, alpha-induced protein 3 |
|
multiple interactions |
ISO |
6 |
138,188,325 |
138,204,451 |
RGD:6480464 |
CTD |
| G |
TNFRSF10A |
tumor necrosis factor receptor superfamily, member 10a |
|
multiple interactions |
EXP |
8 |
23,048,970 |
23,082,680 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFRSF10B |
tumor necrosis factor receptor superfamily, member 10b |
|
multiple interactions |
EXP |
8 |
22,877,646 |
22,926,700 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
multiple interactions |
EXP |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFRSF1A |
tumor necrosis factor receptor superfamily, member 1A |
|
multiple interactions |
EXP |
12 |
6,437,923 |
6,451,283 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases expression |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
multiple interactions |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TNFSF10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
decreases response to substance |
EXP |
3 |
172,223,298 |
172,241,297 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
decreases activity |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
EXP |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TP53 |
tumor protein p53 |
|
multiple interactions |
ISO |
17 |
7,571,720 |
7,590,868 |
RGD:6480464 |
CTD |
| G |
TPM1 |
tropomyosin 1 (alpha) |
|
multiple interactions |
ISO |
15 |
63,334,838 |
63,364,114 |
RGD:6480464 |
CTD |
| G |
TRIB3 |
tribbles homolog 3 (Drosophila) |
|
multiple interactions |
EXP |
20 |
361,308 |
378,203 |
RGD:6480464 |
CTD |
| G |
TSC2 |
tuberous sclerosis 2 |
|
multiple interactions |
ISO |
16 |
2,097,990 |
2,138,713 |
RGD:6480464 |
CTD |
| G |
TSHB |
thyroid stimulating hormone, beta |
|
multiple interactions |
ISO |
1 |
115,572,415 |
115,576,941 |
RGD:6480464 |
CTD |
| G |
TSPAN6 |
tetraspanin 6 |
|
decreases expression |
EXP |
X |
99,883,795 |
99,891,794 |
RGD:6480464 |
CTD |
| G |
TXN |
thioredoxin |
|
multiple interactions |
EXP |
9 |
113,006,092 |
113,018,920 |
RGD:6480464 |
CTD |
| G |
TXN |
thioredoxin |
|
decreases expression |
EXP |
9 |
113,006,092 |
113,018,920 |
RGD:6480464 |
CTD |
| G |
TXN |
thioredoxin |
|
multiple interactions |
ISO |
9 |
113,006,092 |
113,018,920 |
RGD:6480464 |
CTD |
| G |
TXN |
thioredoxin |
|
multiple interactions |
EXP |
9 |
113,006,092 |
113,018,920 |
RGD:6480464 |
CTD |
| G |
TXNL1 |
thioredoxin-like 1 |
|
decreases expression |
EXP |
18 |
54,270,053 |
54,305,920 |
RGD:6480464 |
CTD |
| G |
TXNRD1 |
thioredoxin reductase 1 |
|
multiple interactions |
EXP |
12 |
104,609,557 |
104,744,085 |
RGD:6480464 |
CTD |
| G |
TYMP |
thymidine phosphorylase |
|
multiple interactions |
EXP |
22 |
50,964,181 |
50,968,514 |
RGD:6480464 |
CTD |
| G |
UCP2 |
uncoupling protein 2 (mitochondrial, proton carrier) |
|
multiple interactions |
ISO |
11 |
73,685,716 |
73,693,889 |
RGD:6480464 |
CTD |
| G |
UFM1 |
ubiquitin-fold modifier 1 |
|
multiple interactions |
EXP |
13 |
38,923,942 |
38,937,143 |
RGD:6480464 |
CTD |
| G |
UGDH |
UDP-glucose 6-dehydrogenase |
|
increases expression |
EXP |
4 |
39,500,375 |
39,529,218 |
RGD:6480464 |
CTD |
| G |
UGT1A6 |
UDP glucuronosyltransferase 1 family, polypeptide A6 |
|
multiple interactions |
ISO |
2 |
234,600,321 |
234,681,951 |
RGD:6480464 |
CTD |
| G |
USPL1 |
ubiquitin specific peptidase like 1 |
|
multiple interactions |
EXP |
13 |
31,191,830 |
31,233,686 |
RGD:6480464 |
CTD |
| G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
1 |
101,185,196 |
101,204,601 |
RGD:6480464 |
CTD |
| G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
EXP |
1 |
101,185,196 |
101,204,601 |
RGD:6480464 |
CTD |
| G |
VCAM1 |
vascular cell adhesion molecule 1 |
|
multiple interactions |
ISO |
1 |
101,185,196 |
101,204,601 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
decreases secretion |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
VEGFA |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
6 |
43,737,946 |
43,754,224 |
RGD:6480464 |
CTD |
| G |
XBP1 |
X-box binding protein 1 |
|
increases splicing |
EXP |
22 |
29,190,548 |
29,196,560 |
RGD:6480464 |
CTD |
| G |
XIAP |
X-linked inhibitor of apoptosis |
|
multiple interactions |
EXP |
X |
122,993,662 |
123,047,829 |
RGD:6480464 |
CTD |
| G |
XIAP |
X-linked inhibitor of apoptosis |
|
multiple interactions |
EXP |
X |
122,993,662 |
123,047,829 |
RGD:6480464 |
CTD |
| G |
XRCC1 |
X-ray repair complementing defective repair in Chinese hamster cells 1 |
|
multiple interactions |
EXP |
19 |
44,047,464 |
44,079,730 |
RGD:6480464 |
CTD |
| G |
XRCC3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
|
multiple interactions |
EXP |
14 |
104,163,954 |
104,181,823 |
RGD:6480464 |
CTD |
| G |
ZFAND2A |
zinc finger, AN1-type domain 2A |
|
multiple interactions |
EXP |
7 |
1,192,543 |
1,199,855 |
RGD:6480464 |
CTD |
| G |
ZFP36L2 |
ZFP36 ring finger protein-like 2 |
|
increases expression |
EXP |
2 |
43,449,541 |
43,453,745 |
RGD:6480464 |
CTD |
| G |
ZMYM2 |
zinc finger, MYM-type 2 |
|
decreases expression |
EXP |
13 |
20,532,810 |
20,665,968 |
RGD:6480464 |
CTD |
| G |
ZNF394 |
zinc finger protein 394 |
|
multiple interactions |
EXP |
7 |
99,090,854 |
99,097,877 |
RGD:6480464 |
CTD |
Term paths to the root
|